Reading this on a mobile device? Try our optimized mobile version here: http://r.smartbrief.com/resp/eeeHCfbwoceXoLrNLDSY

January 3, 2013
Sign upForwardArchive
Cancer news and resources for health care professionals

  Patient-Centered Cancer Care 
  • Few cancer patients are advised on fatigue treatments
    Researchers surveyed 160 cancer patients who experienced moderate to severe fatigue and found that just 10% of them were advised to be more physically active or to try other nondrug measures of reducing fatigue. Cancer types played a major role in whether or not patients get fatigue treatments, the study in the journal Supportive Care in Cancer found. HealthDay News (12/27) LinkedInFacebookTwitterEmail this Story
  • Fertility drugs don't raise risk of uterine cancer recurrence
    Women who took fertility drugs after fertility-sparing therapy for uterine cancer were not more likely to experience recurrence than those who didn't receive fertility drugs, according to a study in the journal Obstetrics & Gynecology. Researchers looked at data on 141 patients and found a similar rate of five-year disease-free survival among women who did and didn't take fertility treatments. PhysiciansBriefing.com/HealthDay News (12/26) LinkedInFacebookTwitterEmail this Story
  • Cancer-related deaths higher among psychiatric patients
    Individuals with psychiatric disorders were 30% more likely to die from cancer than were people in the general population, an Australian study in the Archives of General Psychiatry found. Psychiatric patients weren't at greater risk for developing cancer, but it was frequently diagnosed later. HealthDay News (12/19) LinkedInFacebookTwitterEmail this Story
  Emerging Trends, Products & Technologies 
  • Study: CRC screening is no better with online education
    A study of more than 900 women found online educational materials aimed at improving colorectal cancer screening rates were no more effective than printed outreach materials or usual care, according to researchers from Fox Chase Cancer Center and Case Western. Only about 12% of women were screened regardless of educational materials, which gastroenterologist Dr. Hemant Roy said was "flabbergastingly disappointing." WBUR-FM (Boston)/National Public Radio (12/21) LinkedInFacebookTwitterEmail this Story
  • Other News
  Cancer Research & Health Policy 
  • Drug shortages threaten cancer recovery
    Young cancer patients who were unable to take a certain drug because of national supply shortages were more likely to relapse than those who received the preferred treatment, according to a report published in the New England Journal of Medicine. Researchers found that 75% of Hodgkin lymphoma patients who received a substitute medication, cyclophosphamide, stayed cancer-free for two years, compared with 88% who received the first-choice medication mechlorethamine. ABC News/The Associated Press (12/28) LinkedInFacebookTwitterEmail this Story
  • Lifetime cancer risk poised to rise for both men, women
    The lifetime risk of developing cancer is expected to rise to 50% in men and 44% in women by 2027, U.K. researchers said. Despite the predicted increase in cancer cases, they noted that survival rates are going up as well because of better therapies and screening techniques. MedicalDaily.com (12/20) LinkedInFacebookTwitterEmail this Story
  • Other News
  Foundation News 
  • Health Care Professional Tools and Training
    We've developed materials, partnerships and tools that can help patients prepare for, cope with and manage their cancer journey. Talk with your patients about these resources, and utilize them in your practice to help provide comprehensive support. Check them out. LinkedInFacebookTwitterEmail this Story
  • Cancer and Emotional Support
    Iram had been married to his high school sweetheart for nine years when he learned he had brain cancer. He thought that by not talking to his wife about his diagnosis, he was protecting her. After she filed for divorce, Iram wondered if his lack of communication pushed someone he loved away. Learn more about Iram’s story and the emotional support services the LIVESTRONG Foundation offers at LIVESTRONG.org/Iram. LinkedInFacebookTwitterEmail this Story
Learn more about LIVESTRONG ->Facebook  |  Twitter  |  Pinterest  |  YouTube  |  Flickr  |  Homepage

  LIVESTRONG SmartQuote 
It begins to be about how you redefine yourself as a person, drawing on all those things that you have experienced ... making yourself into the new person that you want to be."
--Amy D., cancer survivor

LinkedInFacebookTwitterEmail this Story

 
 
Subscriber Tools
   
Print friendly format  | Web version  | Search past news  | Archive  | Privacy policy

 
Read more at SmartBrief.com
 
About the LIVESTRONG Foundation
The LIVESTRONG Foundation provides free cancer support services to help people cope with the financial, emotional and practical challenges that accompany the disease. Created in 1997 by cancer survivor and philanthropist Lance Armstrong, the Foundation is known for its powerful brand – LIVESTRONG–and for its advocacy on behalf of survivors and their families. With its iconic yellow LIVESTRONG wristband, the Foundation has become a symbol of hope and inspiration around the world. Since its inception, the Foundation has raised nearly $500 million to support cancer survivors and served 2.5 million people affected by the disease. For more information, visit LIVESTRONG.org.

 
Disclaimer
The LIVESTRONG Foundation does not necessarily endorse the opinions that may be mentioned on this site, the articles are published for informational purposes and are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this site.

 
 Recent LIVESTRONG SmartBrief Issues:   Lead Editor:   Kathryn Doherty
     
Mailing Address:
SmartBrief, Inc.®,555 11th ST NW, Suite 600, Washington, DC 20004
 
 
© 1999-2013SmartBrief, Inc.®  Legal Information